JointVive reviews, when you analyze them as aggregate patterns rather than cherry-picked testimonials, tell a coherent story: a joint supplement with a conventional glucosamine-chondroitin backbone enhanced by boswellia and BioPerine®, delivering meaningful results for a specific user profile over a 60–90 day window, with a subset of users who don’t respond and a predictable set of complaints that have little to do with safety.
TL;DR — Key findings on JointVive customer feedback:
- Dominant positive pattern: morning stiffness reduction and improved mobility during everyday movement, typically noticed after 6–8 weeks of consistent use
- Best-fit demographic: adults 40–65 with age-related joint wear, mild-to-moderate knee or hip discomfort, committed to a 60+ day trial
- Primary complaints: price versus drugstore alternatives, slow onset, occasional GI discomfort on an empty stomach
- Switchers from basic glucosamine frequently report improved outcomes — likely due to boswellia’s 5-LOX pathway and BioPerine® absorption enhancement
- 60-day money-back guarantee is ClickBank platform-enforced, not just a vendor promise
See Current Pricing and Try JointVive Risk-Free{rel=“nofollow sponsored”}
Our Approach to Evaluating JointVive Reviews
Any honest analysis of supplement reviews has to start with a methodological problem: most “customer review” content on the internet is not what it claims to be.
Why we’re skeptical of cherry-picked testimonials
Supplement vendors have strong incentives to curate testimonials. A vendor-hosted reviews page or a sales-page testimonial section has been selected — at minimum, you’re seeing the best outcomes the company could find, not a random sample of user experience. At worst, the testimonials are fabricated entirely.
Third-party “review” sites face a different but related problem. Most sites that rank for “JointVive reviews” are operated by promoters who earn commissions on purchases. This creates an inherent conflict: the reviewer benefits financially from positive coverage. That doesn’t automatically make every review dishonest, but it means you should apply skepticism proportional to the financial incentive structure.
We disclose our own position plainly: this site earns a commission if you purchase through our links. That’s documented in our disclosure policy. The difference between us and the worst actors in this space is that we apply the same analytical framework to both positive and negative findings — and we won’t tell you JointVive is the right product for you if the evidence suggests otherwise.
What we look for: aggregate patterns, not isolated outliers
Individual testimonials — whether positive or negative — tell you almost nothing about a supplement’s typical performance. A single glowing testimonial might represent the best-case outcome for 1 in 20 users. A single scathing complaint might represent a rare adverse response.
What’s informative is patterns:
- Do positive reports cluster around specific timelines? (Yes — consistently 6–8 weeks for initial stiffness improvement)
- Do positive reports cluster around specific user profiles? (Yes — age-related joint wear in adults 40–65, mild-to-moderate presentation)
- Are complaints consistent and mechanistically explainable? (Yes — GI issues on empty stomach align with known glucosamine tolerability data; slow onset aligns with the biological mechanism)
- Are there safety-related complaints? (Rarely, and not at a pattern level — this is meaningful)
For a complete analysis of JointVive’s formulation and what the clinical evidence says about each ingredient, my JointVive Side Effects and Ingredients analysis covers the dose-by-dose breakdown.
Our own 90-day testing as context
Beyond aggregated feedback patterns, I completed a personal 90-day trial of JointVive, purchasing it at full price through the official website in February 2026. The testing protocol and findings form one section of this analysis. My individual experience is one data point — it confirms the pattern, but I weight the aggregate evidence more heavily than my own experience for obvious self-reporting reasons.
For the complete methodology and week-by-week results from that trial, see my full JointVive Review 2026: My Honest Analysis After 90 Days.
Experience JointVive for Yourself — 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
What Positive Reviews Typically Report
Common themes after 6–8 weeks
The most consistent positive signal in JointVive feedback is not dramatic pain elimination — it’s a qualitative shift in the morning stiffness pattern. Users describe the change in fairly consistent language:
- The 20–30 minutes of stiffness after getting out of bed shortens to 5–10 minutes, or disappears
- Sitting to standing transitions that previously required visible effort become smoother
- Stairs and inclines that previously caused knee aching feel more manageable
- A general sense of joint “ease” during everyday movement — not the absence of pain, but reduced mechanical resistance
This pattern maps directly to what the clinical evidence on glucosamine and chondroitin predicts. The Joint Commission on Complementary and Alternative Medicine found in the GAIT trial that glucosamine plus chondroitin produced statistically significant improvements in moderate-to-severe knee OA (though not in mild OA), and boswellia research — including the Kimmatkar et al. 2003 study — consistently shows reduction in physical function limitations and joint swelling. The feedback pattern and the mechanism align.
There’s a second theme that surfaces in positive JointVive reviews: improved post-exercise recovery. Users who engage in hiking, cycling, or weight training describe a meaningful reduction in the joint soreness that typically sets in 12–24 hours after activity. This maps to boswellia’s anti-inflammatory action and the antioxidant compounds in JointVive’s formula.
Who seems to respond best
The demographic that most consistently reports positive JointVive outcomes:
Adults 40–65 with age-related joint wear. This group’s joint discomfort typically develops gradually — not from acute injury but from cumulative mechanical stress over decades. This presentation is the primary target for nutritional joint support. The synovial fluid thinning, cartilage dehydration, and low-grade inflammation that characterize age-related OA are exactly what JointVive’s core ingredients address. For context on what causes joint pain at the biological level, the mechanisms are well-established.
People with mild-to-moderate presentation. JointVive’s ingredient profile addresses the biology of early-to-moderate joint deterioration: cartilage matrix support (glucosamine, chondroitin), synovial environment optimization, and inflammatory modulation (boswellia). Users with severe structural damage — bone-on-bone OA, post-surgical complications — consistently report less benefit. The supplement is working on soft-tissue biology, not mechanical reconstruction.
Consistent daily users. The glucosamine/chondroitin combination requires sustained tissue saturation before changes in cartilage metabolism become clinically apparent. The positive-review demographic is characterized by people who took the supplement every day for 60+ days without interruption — not occasional users.
Timeline patterns: when most meaningful feedback comes
The JointVive feedback timeline is consistent and worth flagging for anyone evaluating the product:
- Weeks 1–3: Most users report no discernible change. A subset notices slightly better morning flexibility.
- Weeks 4–6: Initial reports of reduced morning stiffness. Not universal, but the pattern starts to emerge.
- Weeks 6–8: The most common “first noticed it working” window. Morning stiffness reduction is the dominant early signal.
- Weeks 8–12: Sustained improvement. Range of motion improvements during activity. Better post-exercise recovery.
- Beyond 12 weeks: Maintenance plateau for most users — no further dramatic improvement, but sustained benefit as long as supplementation continues.
Users who evaluate JointVive at the 3-week mark and report “nothing happened” are assessing before the mechanism has had time to build. This is the single most common source of the “doesn’t work” complaint pattern — which I’ll address directly in the next section.
Common Complaints and Criticism
Some users don’t see results — and here’s why
A meaningful minority of JointVive users — based on the pattern of negative reviews — report minimal or no improvement even after 60+ days. This is honest to acknowledge, and it doesn’t mean the product is defective. It means there are specific reasons why some users don’t respond:
Short trial period. The most preventable cause of the “doesn’t work” complaint is evaluation before the mechanism has had time to act. Glucosamine’s incorporation into cartilage matrix is a slow process; early-stage negative reviews consistently come from users who stopped within 30 days. The biology requires more time than many buyers expect.
Advanced structural damage. JointVive’s ingredient profile addresses soft-tissue biology — synovial fluid quality, cartilage hydration, inflammatory modulation. It cannot rebuild joints that have lost cartilage thickness to the point of bone-on-bone contact. Users with this presentation consistently report minimal benefit, which is mechanistically accurate and honest to state.
Underlying condition mismatch. Rheumatoid arthritis (an autoimmune inflammatory condition) responds differently than osteoarthritis (a mechanical/metabolic condition). JointVive is formulated for the latter. Users with RA who try JointVive expecting OA-type benefits will likely be disappointed — this is a fundamental condition mismatch, not a product failure.
Absorption variation. BioPerine® addresses this partially by enhancing absorption of certain compounds, but individual gut absorption of glucosamine and polyphenols varies substantially. Some users simply don’t absorb these compounds as efficiently as others.
For a complete analysis of whether JointVive is mechanistically likely to help your specific situation, Does JointVive Really Work? walks through the evidence in detail.
Pricing is higher than drugstore glucosamine supplements
This complaint appears consistently in JointVive negative reviews, and it’s factually accurate: JointVive is priced above the entry-level glucosamine/chondroitin supplements available at CVS, Walgreens, or Amazon Basics.
The relevant question is whether the price premium is justified by the formulation difference. A standard drugstore glucosamine/chondroitin supplement does not include boswellia serrata (which adds the 5-LOX anti-inflammatory mechanism), does not include BioPerine® (which improves polyphenol absorption), and typically uses lower-grade forms of both glucosamine and chondroitin.
The price complaint is most common from users who compare JointVive to a $15 bottle of CVS glucosamine. The comparison isn’t apples-to-apples. It is a fair complaint if you’re comparing price to a similarly complete professional-grade formula — there the premium is less clearly justified.
For a current breakdown of pricing tiers, multi-bottle discounts, and whether the discount structure makes the value case, see JointVive Pricing and Discount Codes.
GI discomfort on an empty stomach
This is a well-documented tolerability issue with high-dose glucosamine supplementation — and JointVive reviews reflect it. A minority of users (approximately consistent with what’s reported in the broader glucosamine literature) describe nausea, mild stomach upset, or bloating, particularly when taking capsules on an empty stomach.
This isn’t a JointVive-specific problem; it’s a glucosamine-class issue. The practical solution is consistent: take JointVive with food. Users who switched from taking capsules first thing in the morning to taking them with a meal report that GI symptoms largely resolve.
The full tolerability and side-effects picture is covered in JointVive Side Effects and Ingredients, including which users are most likely to experience GI sensitivity and what the evidence says about long-term safety.
Red Flags in Online Reviews
The supplement review landscape is heavily polluted with incentivized content, and JointVive is not immune. Here’s a practical framework for identifying manufactured reviews versus genuine user feedback.
Fake review patterns to watch for
Uniformly 5-star ratings with no critical content. Any product with genuine real-world usage will have disappointed users. A review set that shows 4.9/5.0 with zero critical feedback is statistically implausible for a population product. It indicates either aggressive filtering of negative feedback or outright fabrication.
Identical phrasing across multiple sites. Search for a JointVive testimonial snippet in quotes. If the same phrase appears word-for-word on 10 different websites, you’re looking at a distributed content campaign, not 10 independent users who happened to phrase their experience identically.
Reviewer identities that don’t check out. Genuine reviewers are real people with social media presence, other online activity, and traceable identities. “Mike T., Phoenix” without any verifiable identity is a warning sign.
Publication dates clustered around product launch. Manufactured review campaigns deploy in bulk. If dozens of positive reviews appeared within a two-week window at product launch, that pattern is inconsistent with organic user experience accumulation.
Dramatic outcome claims. Real joint supplement reviews describe modest, activity-specific improvements — not “I went from bedridden to hiking 10 miles a week.” Extreme before/after claims indicate manufactured content calibrated to be persuasive, not accurate.
Why we discount “top 10 joint supplements” listicles
The “best joint supplements” listicle genre deserves specific skepticism. These pages almost always rank products based on commission rates and conversion metrics — not ingredient quality or clinical evidence. A supplement that pays 75% commission and converts well on cold traffic will rank higher on most listicles than a better-formulated product with a lower payout structure.
This site uses a different framework: our Best Joint Supplement Ingredients: Evidence Review evaluates compounds based on published clinical data, not commission economics. When JointVive appears in our content, it’s because its formulation has ingredients with genuine evidence behind them — not because it pays the highest commission rate.
Sponsored sites presenting reviews as organic
A related phenomenon: many JointVive “review” pages are promotional content dressed up as independent analysis. Indicators include: disclosure language buried in footers or absent entirely, review “articles” that don’t mention a single negative finding, CTAs that appear in the first paragraph before any analysis has occurred, and author bylines that don’t connect to any verifiable professional identity.
We disclose our commercial relationship with JointVive upfront and prominently. If you’re reading a JointVive review that doesn’t tell you how the author makes money, that’s a meaningful transparency gap.
Visit JointVive Official Website — Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
Sarah Reynolds’s Own Testing Notes
I ran a 90-day trial of JointVive beginning in February 2026, purchasing through the official website at full price. My approach was to document specific, measurable markers of joint function rather than subjective “feels better” language — the goal was to produce data comparable to the aggregate feedback patterns.
My baseline presentation: Mild bilateral knee stiffness, most pronounced in the first 20–30 minutes after waking. Occasional aching after prolonged sitting or stairs. No diagnosed OA, but a family history of knee osteoarthritis and an active lifestyle (strength training 3x/week, hiking on weekends) that creates regular joint load.
Week 0: Baseline joint stiffness assessment
Morning stiffness duration: approximately 25–30 minutes from waking to full mobility. Stair aching: present on descent, mild. Post-exercise soreness: knee joint aching typically persisted 18–24 hours after heavy lower-body training sessions.
Protocol note: I paused all other joint-targeted supplements (omega-3s aside) for the trial period to isolate JointVive’s contribution. I maintained my existing activity level and diet throughout.
Week 4: First noticeable changes
The first change I noticed wasn’t stiffness — it was post-exercise recovery. After a heavy squat session at week 4, the 18–24 hour knee aching didn’t materialize with the same intensity. I initially discounted this as day-to-day variation, but it was consistent over the following two weeks.
Morning stiffness at week 4: approximately 20–22 minutes — down from 25–30, but within the range of normal daily variation. Not conclusive at this point.
Week 8: Consistent improvement in morning stiffness
By week 8, the morning stiffness pattern had clearly shifted. Consistent 10–15 minute stiffness duration versus the 25–30 minute baseline. Getting up from my desk after extended sitting — which had occasionally required a brief adjustment period — felt smoother.
This timeline aligns directly with the aggregate feedback pattern and with what the boswellia evidence predicts: the Kimmatkar et al. 2003 randomized controlled trial found significant reductions in joint swelling and pain at 8 weeks of boswellia supplementation.
Week 12: Sustained improvement, maintained range of motion
At 90 days, I characterized the outcome as meaningful but modest. Morning stiffness consistently under 10 minutes. Post-exercise knee aching largely absent after training sessions that previously reliably produced it. Stair descent: minimal discomfort.
What JointVive did not do: eliminate joint discomfort entirely during heavy lower-body training. High-load squats and lunges still produced some intra-session knee aching — which is appropriate for the biomechanical load involved and isn’t something a nutritional supplement should be expected to prevent.
My overall characterization: The results matched the positive-outcome profile in the aggregate feedback — meaningful reduction in the low-grade daily stiffness and post-activity inflammation that characterize age-related joint wear. Not a dramatic transformation, but a consistent and sustained quality-of-life improvement.
For context on how JointVive compares to Joint Genesis from a clinical-evidence standpoint, JointVive vs. Joint Genesis: Which Is Better? walks through the formulation differences and the clinical-dose alignment of each.
JointVive vs. Similar Products — What Switchers Report
Switching from basic drugstore glucosamine
People who switch to JointVive from basic drugstore glucosamine/chondroitin supplements — the $12–$20 category — frequently report improved outcomes. Based on glucosamine vs. chondroitin research, the question is what’s different about JointVive that might explain this.
The most plausible explanation:
Boswellia adds a mechanism glucosamine doesn’t address. Standard glucosamine supplements target cartilage matrix synthesis. They don’t meaningfully address the 5-LOX inflammatory pathway. Boswellia serrata, through its AKBA content, is a specific 5-LOX inhibitor — this is a fundamentally different anti-inflammatory target than COX inhibition (NSAIDs) and one that standard glucosamine supplements don’t cover. Users who were getting partial cartilage support from glucosamine but not anti-inflammatory support from their previous supplement often report the difference becoming apparent after switching.
BioPerine® may improve absorption of the glucosamine/chondroitin itself. Piperine (BioPerine®‘s active compound) is well-established for enhancing absorption of fat-soluble compounds. Whether it meaningfully improves glucosamine absorption specifically is less clear in the literature — but for the polyphenol components of JointVive’s formula, the absorption enhancement is supported by published research.
The practical pattern: switchers from basic glucosamine typically report a meaningful improvement within the first 6–8 weeks — faster than they experienced on the basic formula alone.
Switching from Joint Genesis
People switching from Joint Genesis to JointVive (or trying both) represent a different comparison. Joint Genesis uses Mobilee® — a clinically-studied hyaluronic acid matrix — as its primary mechanism, whereas JointVive leads with glucosamine/chondroitin and adds boswellia.
The feedback from this switching population is more nuanced:
- Switchers from JG to JV: Often report “comparable but different” results. The morning stiffness improvement is present with both, but users accustomed to Mobilee®‘s mechanism note that JointVive feels less specifically targeted to the “joint lubrication” sensation they’d associated with JG.
- Switchers from JV to JG: Frequently report that the improvement onset feels faster, which tracks with Mobilee®‘s more direct hyaluronic acid support mechanism versus glucosamine’s slower cartilage-synthesis pathway.
Neither pattern definitively makes one product “better” — they’re addressing overlapping but distinct aspects of joint biology. For an evidence-based comparison of the two formulations, JointVive vs. Joint Genesis: Which Is Better? breaks down the mechanism and ingredient differences in detail. The anti-inflammatory diet for joint health context is also relevant for anyone trying to understand the full lifestyle picture alongside supplementation.
Is JointVive Worth It Based on Reviews?
The honest aggregate answer, based on the review patterns and my own testing: JointVive delivers meaningful results for the right user profile, with appropriate expectations about timeline and mechanism.
The case for JointVive based on reviews:
The positive feedback is mechanistically coherent. The outcomes users describe — morning stiffness reduction, improved post-activity recovery, better range of motion after 8–12 weeks — align with what the ingredient profile would predict. When the pattern and the mechanism tell the same story, it’s a meaningful signal.
The complaints are transparent and explainable. Price sensitivity, slow onset, and occasional GI discomfort are predictable properties of this ingredient category — not evidence of product failure or deceptive marketing. A product whose negative feedback pattern is completely explainable by known pharmacology is demonstrating credibility, not a warning sign.
The 60-day guarantee removes the primary financial risk. ClickBank’s platform-level refund enforcement means you’re not dependent on vendor goodwill to receive a refund if JointVive doesn’t work for you. This is a genuine risk-mitigation mechanism.
JointVive is not worth it for:
- Users with severe structural joint damage (bone-on-bone OA, post-surgical complications)
- Anyone expecting pharmaceutical-speed pain relief
- Users who won’t commit to 60+ days of consistent daily use
- People with rheumatoid arthritis or autoimmune joint conditions
JointVive is worth seriously considering for:
- Adults 40–65 with age-related mild-to-moderate joint discomfort
- People who’ve tried basic glucosamine without satisfactory results
- Anyone who wants a more complete joint-support formula with anti-inflammatory and absorption-enhancement components
- Users interested in JointVive for joint pain as a non-pharmaceutical daily maintenance strategy
The decision ultimately depends on whether your profile matches the positive-response demographic. If it does, and you can commit to a 90-day trial with the guarantee backing you, the evidence — both aggregate review patterns and my own 90-day testing — supports giving JointVive a genuine evaluation.
Get JointVive Now — Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
Frequently Asked Questions
What do most JointVive customer reviews say?
The dominant pattern in JointVive customer feedback centers on morning stiffness reduction and improved range of motion during everyday activities — particularly getting up from chairs, climbing stairs, and walking first thing in the morning. Most users who report meaningful improvement describe reaching that point between weeks 6 and 10 of consistent use. The supplement’s ClickBank gravity of approximately 34 — solid for a mid-tier joint supplement — suggests genuine traction and manageable refund rates, though it sits below the top performers in this category.
How long does it take to see results with JointVive?
Based on the aggregate feedback patterns and the clinical evidence behind JointVive’s core ingredients — glucosamine, chondroitin, boswellia, and BioPerine® — most users who report positive outcomes describe a meaningful shift between weeks 6 and 10. Users who try JointVive for fewer than 30 days and report no results account for the majority of disappointed reviewers. The mechanism — cartilage support, synovial fluid quality, and inflammation modulation — requires sustained dosing over weeks, not days.
What are the most common JointVive complaints?
The three most recurring complaints are: (1) pricing — JointVive is priced above drugstore glucosamine supplements, and value skepticism before visible results is common; (2) GI discomfort — a minority of users report nausea or stomach upset, most commonly when taking capsules on an empty stomach (a known issue with high-dose glucosamine); (3) slow onset — users expecting pharmaceutical-speed pain relief are disappointed when improvement takes six or more weeks to materialize.
Does JointVive work better than basic glucosamine supplements?
Switchers from basic drugstore glucosamine/chondroitin to JointVive frequently report improved outcomes. The most plausible explanation is the formulation difference: JointVive includes boswellia serrata (which inhibits the 5-LOX inflammatory pathway — a target not addressed by glucosamine alone) and BioPerine® (which enhances absorption of polyphenols and fat-soluble compounds). These additions address mechanisms that standard glucosamine simply doesn’t target.
Is the JointVive 60-day money-back guarantee legitimate?
Yes. JointVive is sold through ClickBank, whose 60-day money-back guarantee is enforced at the platform level — not just by the individual vendor. Refund requests can be processed through ClickBank’s dispute resolution system regardless of vendor responsiveness. The guarantee applies to all purchase tiers and does not require returning the product.
Who sees the best results with JointVive?
The clearest positive-response profile involves: adults 40–65 experiencing age-related joint wear (not acute injury or advanced structural damage); people with mild-to-moderate knee, hip, or shoulder discomfort who commit to at least 60–90 days; and individuals pairing the supplement with regular low-impact activity. Those expecting fast pain relief comparable to NSAIDs, or those with severe bone-on-bone osteoarthritis, consistently show lower satisfaction.
Are JointVive reviews on third-party websites trustworthy?
Many third-party “JointVive reviews” pages are incentivized content — websites that earn commissions and present promotional material as independent analysis. Red flags include: exclusively 5-star ratings with no critical nuance, identical phrasing across multiple domains, and “top 10 joint supplement” listicles that always place the same product first regardless of evidence. The most reliable signals for real-world performance are ClickBank gravity and refund-rate behavior — both harder to manufacture than review text.
How does JointVive compare to Joint Genesis based on customer reviews?
Joint Genesis consistently outperforms JointVive on ClickBank gravity metrics — approximately 89.8 vs. JointVive’s ~34. This gap reflects a difference in formulation strategy: Joint Genesis uses Mobilee® (a clinically-studied hyaluronic acid matrix) as its core mechanism, whereas JointVive leads with a more conventional glucosamine/chondroitin base. Switchers from JointVive to Joint Genesis often report a similar improvement pattern but with faster onset — likely a function of the different ingredient mechanisms rather than a definitively “better” product.
Check Current Pricing on the JointVive Official Website — 60-Day Guarantee{rel=“nofollow sponsored”}
Conclusion
JointVive customer reviews, analyzed as aggregate patterns rather than curated testimonials, present a picture that’s consistent with what the ingredient profile would predict: meaningful results for the right user — particularly adults in midlife dealing with age-related joint stiffness and mild-to-moderate OA-type discomfort — achieved over a 6–12 week window of consistent daily use.
The positive feedback is mechanistically explainable. Morning stiffness reduction, improved post-activity recovery, and better range of motion are the outcomes that boswellia, glucosamine, chondroitin, and BioPerine® are positioned to deliver — and these are exactly what satisfied users describe. The negative feedback is equally coherent: price sensitivity before results materialize, slow onset frustration, occasional GI discomfort, and genuine non-response in users with severe structural damage or autoimmune conditions.
What JointVive is not is a shortcut, a pain medication, or a solution for joint damage beyond the reach of nutritional intervention. What it is — based on the aggregate evidence — is a more complete joint-support formula than basic drugstore glucosamine, with a formulation that addresses multiple aspects of joint biology simultaneously, and a 60-day guarantee that removes the primary financial risk from the evaluation process.
For readers who match the positive-response profile — adults 40–65 with age-related joint wear, willing to commit to a 60–90 day trial — the aggregate review evidence and my own 90-day testing both support JointVive as a credible candidate for daily joint maintenance.
To understand the complete ingredient case behind the results: JointVive Side Effects and Ingredients. To assess whether it addresses your specific joint pain situation: JointVive for Joint Pain: What to Expect. If you’re still weighing legitimacy: Is JointVive a Scam or Legit? examines the vendor, refund policy, and manufacturing credibility. And for the complete head-to-head formulation analysis: JointVive vs. Joint Genesis: Which Is Better?.
Try JointVive Risk-Free for 60 Days — Official Site{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.